West China Hospital: Head and Neck Neoplasms trials

The registry lists 19 Head and Neck Neoplasms studies with West China Hospital as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 1 6Phase 2 7Phase 3 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tai Chi for Cancer-Related Fatigue During Radiotherapy in Patients With Head and Neck CancerRecruitingNCT07809776Not applicable
• Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck CancerNot yet recruitingNCT07704372Phase 2
• Akkermansia Muciniphila (AKK) for Radiation-Induced Skin InjuryRecruitingNCT07635277Phase 1
• Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck TumorsRecruitingNCT07625423Phase 1
• Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid TumorsNot yet recruitingNCT07583914Phase 1
• Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation TherapyRecruitingNCT07467083Phase 3
• Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation DermatitisRecruitingNCT07353671Phase 2/3
• Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck CancersNot yet recruitingNCT07072325Phase 1
• Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck CancerRecruitingNCT06272617Not applicable
• A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck CancerNot yet recruitingNCT04405154Phase 2
• Digital Phenotyping of Psychological Distress in Skin Cancer PatientsWithdrawnNCT07670403
• Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck TumorsActive, not recruitingNCT07040969Phase 2
• Plasma Calcitonin Gene-Related Peptide (CGRP) Levels in Patients With Head and Neck Malignancies Undergoing RadiotherapyCompletedNCT07029373
• Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCCWithdrawnNCT06804850Phase 2
• Systematic Oral Education for Prevention of Oral-related Complications Caused by Radiotherapy for Head and Neck CancerCompletedNCT06690346Not applicable
• Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous CarcinomaCompletedNCT06494189Phase 1
• Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .CompletedNCT06484166Not applicable
• A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing RadiotherapyCompletedNCT06251050Phase 1/2
• Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell CarcinomaCompletedNCT05517330Phase 2